These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32424554)
1. Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes. do Patrocinio AB; Cabral FJ; Bitencourt ALB; Brigato OM; Magalhães LG; de Lima Paula LA; Franco L; Guerra-Sá And R; Rodrigues V Parasitol Res; 2020 Jul; 119(7):2159-2176. PubMed ID: 32424554 [TBL] [Abstract][Full Text] [Related]
2. Deubiquitinating enzymes as possible drug targets for schistosomiasis. Barban do Patrocínio A; Cabral FJ; de Paiva TH; Magalhães LG; Paula LAL; Brigato OM; Guerra-Sá R; Rodrigues V Acta Trop; 2021 May; 217():105856. PubMed ID: 33577811 [TBL] [Abstract][Full Text] [Related]
3. The role of 19S proteasome associated deubiquitinases in activity-dependent hippocampal synaptic plasticity. Yun D; Zhuang Y; Kreutz MR; Behnisch T Neuropharmacology; 2018 May; 133():354-365. PubMed ID: 29407217 [TBL] [Abstract][Full Text] [Related]
4. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells. Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154 [TBL] [Abstract][Full Text] [Related]
5. Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma. Jiang L; Sun Y; Wang J; He Q; Chen X; Lan X; Chen J; Dou QP; Shi X; Liu J J Exp Clin Cancer Res; 2019 Nov; 38(1):453. PubMed ID: 31694672 [TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization and role of the proteasome in the oxidative stress response of adult Schistosoma mansoni worms. de Paula RG; Ornelas AM; Morais ER; Borges Wde C; Natale M; Magalhães LG; Rodrigues V Parasitol Res; 2014 Aug; 113(8):2887-97. PubMed ID: 24870249 [TBL] [Abstract][Full Text] [Related]
8. The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells. Schmidt M; Altdörfer V; Schnitte S; Fuchs AR; Kropp KN; Maurer S; Müller MR; Salih HR; Rittig SM; Grünebach F; Dörfel D Neoplasia; 2019 Jul; 21(7):653-664. PubMed ID: 31132676 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of proteasome deubiquitinating activity as a new cancer therapy. D'Arcy P; Brnjic S; Olofsson MH; Fryknäs M; Lindsten K; De Cesare M; Perego P; Sadeghi B; Hassan M; Larsson R; Linder S Nat Med; 2011 Nov; 17(12):1636-40. PubMed ID: 22057347 [TBL] [Abstract][Full Text] [Related]
10. Effects of proteasome inhibitor MG-132 on the parasite Schistosoma mansoni. Morais ER; Oliveira KC; Paula RG; Ornelas AMM; Moreira ÉBC; Badoco FR; Magalhães LG; Verjovski-Almeida S; Rodrigues V PLoS One; 2017; 12(9):e0184192. PubMed ID: 28898250 [TBL] [Abstract][Full Text] [Related]
11. Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress. Brnjic S; Mazurkiewicz M; Fryknäs M; Sun C; Zhang X; Larsson R; D'Arcy P; Linder S Antioxid Redox Signal; 2014 Dec; 21(17):2271-85. PubMed ID: 24011031 [TBL] [Abstract][Full Text] [Related]
12. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase. Yue X; Zuo Y; Ke H; Luo J; Lou L; Qin W; Wang Y; Liu Z; Chen D; Sun H; Zheng W; Zhu C; Wang R; Wen G; Du J; Zhou B; Bu X Biochem Pharmacol; 2017 Aug; 137():29-50. PubMed ID: 28476333 [TBL] [Abstract][Full Text] [Related]
13. The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death. Wang X; Stafford W; Mazurkiewicz M; Fryknäs M; Brjnic S; Zhang X; Gullbo J; Larsson R; Arnér ES; D'Arcy P; Linder S Mol Pharmacol; 2014 Jun; 85(6):932-45. PubMed ID: 24714215 [TBL] [Abstract][Full Text] [Related]
14. Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with Jiang ZY; Hong J; Zhang JH; Wang XF; Ma YS; Xiong ZX; Sun HR; Cheng C; Xie BZ; Liu JB; Ouyang YG; Fu D Technol Cancer Res Treat; 2022; 21():15330338221119745. PubMed ID: 35971329 [No Abstract] [Full Text] [Related]
16. A ubiquitinome analysis to study the functional roles of the proteasome associated deubiquitinating enzymes USP14 and UCH37. van der Wal L; Bezstarosti K; Demmers JAA J Proteomics; 2022 Jun; 262():104592. PubMed ID: 35489684 [TBL] [Abstract][Full Text] [Related]
17. Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition. Patel K; Ahmed ZS; Huang X; Yang Q; Ekinci E; Neslund-Dudas CM; Mitra B; Elnady FA; Ahn YH; Yang H; Liu J; Dou QP Future Med Chem; 2018 Sep; 10(17):2087-2108. PubMed ID: 30066579 [TBL] [Abstract][Full Text] [Related]
18. MJD and OTU deubiquitinating enzymes in Schistosoma mansoni. Pereira RV; Gomes Mde S; Costa MP; Passos LK; Borges Wde C; Guerra-Sá R Parasitol Res; 2015 Aug; 114(8):2835-43. PubMed ID: 25924794 [TBL] [Abstract][Full Text] [Related]
19. Proteasome stress responses in Schistosoma mansoni. de Paula RG; de Magalhães Ornelas AM; Morais ER; de Souza Gomes M; de Paula Aguiar D; Magalhães LG; Rodrigues V Parasitol Res; 2015 May; 114(5):1747-60. PubMed ID: 25663105 [TBL] [Abstract][Full Text] [Related]
20. Smp38 MAP Kinase Regulation in Avelar LDGA; Gava SG; Neves RH; Silva MCS; Araújo N; Tavares NC; Khal AE; Mattos ACA; Machado-Silva JR; Oliveira G; Mourão MM Front Immunol; 2019; 10():21. PubMed ID: 30733716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]